BIV currently runs four accelerator programmes per year in New York and Singapore. But with Bel on board, the US-based venture fund says it hopes to open an accelerator in Paris in 2021.For Bel, backing the New Protein Fund aligns with its commitment to ‘enabling a better balance between plant and animal proteins in food’. The group has already announced plans to roll out plant-based products within the range of its main brands, as well as under a new international brand.

Source: Bel Group backs plant-based innovation with Paris accelerator on the cards

By Grégory Maubon

Leading Innovation ++ on the Field ++ with a Purpose => I used AI in cultivated meat industry to optimize bioreactor design and to dramatically improve the efficiency and quality of production. I developed high quality 3D imagery process in a biotechnological startup to disrupt the drug discovery methods.

Leave a Reply

Your email address will not be published. Required fields are marked *